polyDNA Survey: Shingles Treatments and Their Side Effects
Rochester, NY (PRWEB) September 09, 2013 -- polyDNA’s monthly survey, taken during August 2013, showed that many people ask about treatments for a herpes zoster (shingles) outbreak. More specifically, they wanted to know which treatments have no side effects. Therefore, polyDNA decided to answer these questions on its website.
polyDNA found that up to 70% of respondents knew about Zostavax®, the vaccine for herpes zoster. The CDC says on its website that “(Zostavax®) is recommended for use in people 60 years old and older to prevent shingles. The older a person is, the more severe the effects of shingles typically are, so all adults 60 years old or older should get the shingles vaccine (1).”
However, in many cases, Zostavax fails. That is, immunization with Zostavax does not provide the expected protection against Shingles outbreaks, according to a study published in 2013 in the journal Advances in Pharmacology (2). The authors of another study also said that “additional doses of the herpes zoster vaccine did not give improved immune responses in (the) elderly (3).” The second study was published in The New England Journal of Medicine in June 2005.
Moreover, according to Drugs.com, Zostavax may also cause “angina pectoris, coronary artery disease, coronary occlusion, cardiovascular disorder, myocardial ischemia, congestive heart failure, and myocardial infarction (4)”.
In addition to the herpes zoster vaccine, there are two drugs used to reduce the symptoms of a Shingles outbreak. However, almost 90% of survey respondents had never heard of Lyrica and Neurontin, or the many side effects users may experience from these drugs.
For instance Lyrica has a long list of potential side effects. As Drugs.com says on its website (5), “Along with its needed effects, pregabalin (the active ingredient contained in Lyrica) may cause some unwanted effects (5).” These commonly include: Accidental injury, bloating or swelling of the face, arms, hands, lower legs, or feet, blurred vision, burning, tingling, numbness or pain in the hands, arms, feet, or legs, change in walking and balance, clumsiness, confusion, delusions, dementia, difficulty having a bowel movement (stool), difficulty with speaking, double vision, dry mouth, fever, headache, hoarseness, increased appetite, lack of coordination, loss of memory, lower back or side pain, painful or difficult urination, problems with memory, rapid weight gain, seeing double, sensation of pins and needles, shakiness and unsteady walk, sleepiness or unusual drowsiness, stabbing pain, swelling, tingling of the hands or feet, trembling, or other problems with muscle control or coordination, and unusual weight gain or loss (5).”
Likewise, Drugs.com also lists a great many side effects for Neurontin. “Along with its needed effects, gabapentin (the active ingredient contained in Neurontin) may cause some unwanted effects (6).” These commonly include: “Clumsiness or unsteadiness, continuous, uncontrolled, back-and-forth, or rolling eye movements, Blurred vision, cold or flu-like symptoms, delusions, dementia, hoarseness, lack or loss of strength, lower back or side pain, swelling of the hands, feet, or lower legs, and trembling or shaking (6).”
Almost 100% of survey respondents had never heard of Gene-Eden-VIR, a natural Shingles remedy that helps the immune system target the latent varicella zoster virus (VZV). Gene-Eden-VIR was proven to be safe and effective in a recent clinical study. The study was published in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs on August 12, 2013 (7).
The study showed that Gene-Eden-VIR reduced Shingles symptoms in individuals already infected with the latent herpes zoster virus (VZV). Study authors wrote that, “individuals infected with the VZV, …reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (7).” The study authors also wrote that “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (7).”
It is important for individuals to know about safe and effective remedies like Gene-Eden-VIR since Shingles can cause intense pain, and long-lasting nerve damage. As Milner Carden, an 83-year-old cancer patient who contracted shingles last fall said in an article published by the Tullahoma News on September 7, “I’ve suffered more from shingles in the last 11 months than I ever have from anything else in all my years combined. It started on the back of my neck, and I still have a lot of pain there, as well as around the side of my head. It gets so bad, I can’t even sleep. I wouldn’t wish it on my worst enemy (8).”
polyDNA therefore recommends Gene-Eden-VIR to those infected with the latent herpes zoster virus (VZV).
To view the entire paper on Gene-Eden-VIR,
visit: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101
To learn more about Gene-Eden-VIR please visit: http://www.gene-eden-kill-virus.com.
###
References:
(1) http://www.cdc.gov/vaccines/vpd-vac/shingles/vacc-need-know.htm
(2) http://www.ncbi.nlm.nih.gov/pubmed/23886000
(3) http://www.ncbi.nlm.nih.gov/pubmed/15930418
(4) http://www.drugs.com/sfx/zostavax-side-effects.html
(5) http://www.drugs.com/sfx/lyrica-side-effects.html
(6) http://www.drugs.com/sfx/neurontin-side-effects.html
(7) scirp.org/journal/PaperInformation.aspx?PaperID=36101
(8) tullahomanews.com/?p=18081
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.
Mike Davis, PolyDNA, http://gene-eden-kill-virus.com/, +1 (585) 250-9999, [email protected]
Share this article